← FDA Drug Approvals (Drugs@FDA)

MONTELUKAST SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANBISON LAB · Approved 2015-11-05

Drug application

FDA Application #

ANDA205695

Application type

Abbreviated New Drug Application (Generic)

Brand name

MONTELUKAST SODIUM

Generic name

Montelukast Sodium

Active ingredients

MONTELUKAST SODIUM

Dosage form

TABLET, CHEWABLE

Route

ORAL

Marketing status

Prescription

Sponsor

ANBISON LAB

First approval

2015-11-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown